Clindamycin palmitate hydrochloride labels and packages
| Clindamycin palmitate hydrochloride |
|---|
| CLINDAMYCIN PALMITATE HYDROCHLORIDE® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Microbiology |
| Indications and Usage |
| Contraindications |
| Warnings |
| Precautions |
| Adverse Reactions |
| Overdosage |
| Dosage and Administration |
| How Supplied |
| Labels and Packages |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
Mfd. by: Lyne Laboratories, Inc. Brockton, MA 02301
R4-08/12
NDC 0374-5070-01
Clindamycin Palmitate Hydrochloride for Oral Solution, USP (Pediatric)
75 mg*/5 mL when reconstituted
100 mL (when mixed) Rx only
Date of reconstitution ________________________
Warning - NOT FOR INJECTION Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Do not refrigerate reconstituted solution.
Keep container tightly closed. Shake well before each use. Discard any unused portion two weeks after reconstitution.
DOSAGE AND USE: See accompanying prescribing information.
Reconstitute with 75 mL of water. Add a large portion of the water and shake vigorously; add the remainder of the water and shake until the solution is uniform.
- When reconstituted with water as directed, each 5 mL (teaspoonful)
of solution contains clindamycin palmitate HCl equivalent to 75 mg clindamycin.
Mfd. by: Lyne Laboratories, Inc. Brockton, MA 02301
R4-08/12
References
http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e1cb8caa-1e49-41e7-bbd8-a2e75bea2fe4